Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    15148277 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Prevention of Chemotherapy-Induced Cardiotoxicity in High-Risk Patients
Condition: Chemotherapy-Induced Cardiotoxicity Revealed by TnI Increase.
Intervention: Drug: oral enalapril
2 Active, not recruiting Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb
Condition: Lymphoma
Interventions: Drug: RCOMP;   Drug: RCHOP
3 Completed Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients
Conditions: Breast Cancer Female;   Doxorubicin Induced Cardiomyopathy
Interventions: Drug: Doxorubicin;   Device: Achieva, Philips Medical Systems (3T magnet);   Drug: Gadoterate Meglumine

Study has passed its completion date and status has not been verified in more than two years.